Latest / Stock Movers / Seagate Slips, NextEra Lower, Regeneron Tumbles
Transcript
- 0:02Speaker 1: Bloomberg Audio Studios, podcasts, radio news.
- 0:08Speaker 2: The Stock Movers report your roundup of companies making moves
- 0:12Speaker 2: in the stock market, harnessing the power of Bloomberg Data.
- 0:16Speaker 1: I'm Tim Steinebeck along with Carol Masser. We are joined
- 0:20Speaker 1: by bloomerg Execti's reporter Alexandra Semenova. She is holding down
- 0:23Speaker 1: the fort at the Bloomberg Studios at headquarters. Alex What
- 0:28Speaker 1: are you.
- 0:28Speaker 3: Watching, hey, guys. So a big unwind continuing to take
- 0:31Speaker 3: hold in those AI infrastructure names that have been driving
- 0:34Speaker 3: this rally for the last several weeks. The first company
- 0:37Speaker 3: that I'm taking a look at today is Seagate Technology.
- 0:41Speaker 3: Shares there are down about ten percent, which is the
- 0:43Speaker 3: worst day since last April during the tariff sell off.
- 0:46Speaker 3: This is after comments from management at a JP Morgan
- 0:50Speaker 3: conference earlier today saying that they don't think that they'll
- 0:54Speaker 3: be able to keep up with soaring demand for their chips.
- 0:57Speaker 3: CEO David Masley said new factories would quote take too long,
- 1:02Speaker 3: and that is enough to send investors running, taking some
- 1:05Speaker 3: profits there after a really strong eight weeks for the company.
- 1:08Speaker 3: This is, of course, submit a toward rally in the
- 1:11Speaker 3: broader semiconductor sector. Just taking a look today at the
- 1:14Speaker 3: Philadelphia Semiconductor Stock Exchange Index that is also down four
- 1:19Speaker 3: point two percent. This is as other memory chip makers
- 1:22Speaker 3: also fell today.
- 1:23Speaker 2: Guys.
- 1:24Speaker 4: All right, so Cgate one of the big laggards in
- 1:26Speaker 4: the trade today. Yeah, quite a big dip to the downside,
- 1:30Speaker 4: top gainer, top decliner. Excuse me, in both the S
- 1:33Speaker 4: and P and the Nasdaq one hundered. All right, let's
- 1:36Speaker 4: kick it on over to the energy patch. I mean
- 1:38Speaker 4: this was like bam, a deal in the space today.
- 1:41Speaker 3: Yeah, mega deal Monday for sure. Next Era Energy agree
- 1:45Speaker 3: to buy Dominion Energy for about sixty seven billion dollars
- 1:49Speaker 3: in stock. This is the biggest power acquisition ever. This
- 1:53Speaker 3: merger creates a giant utility that expands from Florida to
- 1:56Speaker 3: some of the data centers in Virginia and also underscores
- 2:00Speaker 3: the insatiable demand for AI infrastructure that is pushing utilities
- 2:04Speaker 3: to seek greater size and clout amid this surge and
- 2:07Speaker 3: demand for power, The deal would position next Era as
- 2:10Speaker 3: the dominant utility in a region that is struggling to
- 2:14Speaker 3: meet electricity consumption, and Next Era would pay the equivalent
- 2:17Speaker 3: of about seventy six dollars per share for Dominion. The
- 2:21Speaker 3: company said this in a statement today, confirming Bloomberg reporting
- 2:24Speaker 3: that represents a takeover premium of about twenty three percent
- 2:28Speaker 3: based on Friday's closing price.
- 2:30Speaker 4: I feel like that's such a sign of the times
- 2:32Speaker 4: in terms of what's going on. All right, Alex, Let's
- 2:35Speaker 4: go on over to Regeneron, which is also coming under
- 2:38Speaker 4: some pressure today.
- 2:40Speaker 3: Yeah, some disappointing news today for this company. Just taking
- 2:43Speaker 3: a look at the stock price right now, it's down
- 2:44Speaker 3: more than ten percent, the worst. Actually, it's been underperforming
- 2:49Speaker 3: for a while. This is after it failed Phase three testing.
- 2:53Speaker 3: This led to at least ten analysts downgrades after it
- 2:56Speaker 3: failed to the testing for its melanoma drug. Biotech was
- 3:00Speaker 3: aiming to show improvement in patients with metastatic melanoma, but
- 3:04Speaker 3: they didn't have a statistically significant enough number for how
- 3:09Speaker 3: long patients lived before their cancer advance compared to competitor
- 3:13Speaker 3: merks K Truda. Bimo analyst said that this trial was
- 3:17Speaker 3: a defining moment for the company in the first half
- 3:20Speaker 3: of twenty twenty six and that sentiment was inextricably tied
- 3:23Speaker 3: to these results, So that is why the stock is
- 3:26Speaker 3: down so much today.
- 3:28Speaker 2: The Stock Movers Report from Bloomberg Radio. Check back with
- 3:32Speaker 2: us throughout the day for the latest roundup of companies
- 3:35Speaker 2: making news on Wall Street and for the latest market
- 3:38Speaker 2: moving headlines. Listen to Bloomberg Radio Live, catch us on YouTube,
- 3:43Speaker 2: Bloomberg dot com, and on Applecarplay and Android Auto with
- 3:46Speaker 2: the Bloomberg Business app.